Nigeria

Hepatitis can’t wait, know your status today-stakeholders urge Nigerians

Format
News and Press Release
Source
Posted
Originally published
Origin
View original

**Abuja, 29 July, 2021 **- Philemon Lar, a 39-year-old farmer living in Bokkos local government area (LGA) in Plateau State, Nigeria, got to know about his Hepatitis status in 2015 when he went to the hospital to donate blood for his cousin who was to undergo surgery.

“It was after the donation process that the laboratory technologist called me and informed me that my blood could not be used as it was reactive for hepatitis B. I was initially scared, however, a nurse at the hospital allayed my fears. I still do regular medical checks, and I have since been careful with my diet and desist from taking alcoholic or any fermented drink”, he says.

The World Health Organization (WHO) estimates that in Africa including Nigeria, more than 90 million people are living with hepatitis, accounting for 26% of the global total. Nigeria, with an estimated population of 190 million people, has a prevalence rate of 8.1 (16 million) and 1.1% (2.2 million) for hepatitis B virus (HBV) and hepatitis C virus (HCV) among adult aged 15-64 years respectively (based on the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) report), but many like Mr Lar, get to know about their hepatitis status by chance or when already ill.

Commemorating World Hepatitis Day 2021

Due to the severity of the disease, Nigeria on 28 July joined WHO to mark 2021 edition of World Hepatitis Day with a ministerial Press briefing to raise awareness on viral hepatitis – infection of the liver, which, when chronic, can cause severe liver disease and liver cancer.

At the event with over 20 journalists in attendance, Nigeria’s Minister of Health, Dr Osagie Ehanire urges all Nigerians to work together to eliminate the silent killer, viral hepatitis by going to any health facility and get screened, as it is a simple rapid testing exercise.

He noted that has become imperative to improve community engagement, political leadership, testing and treatment, and scale up high impact intervention because the mortality rate from both infections remains alarming despite limited global progress in addressing the scourge.

This year’s theme “Hepatitis can’t wait” with a national sub theme: “National Ownership and Financing for Viral Hepatitis Elimination” is an urgent call to governments and stakeholders to improve effort towards eliminating a disease that globally kills one person every 30 seconds, even in the current COVID-19 crisis.

In his goodwill message, WHO Nigeria Country Representative, Dr Walter Kazadi Mulombo commended the efforts of the government towards elimination of viral hepatitis, saying Nigeria is among the 14 countries that is implementing hepatitis B birth-dose vaccine, and routinely screen all donated blood and blood products for HBV and HCV.

He noted that though the birth dose and pentavalent hepatitis vaccine is provided free of charge for all under 5 children, more needs to be done to prevent mother to child transmission (PMTCT) as the health system is challenged with ensuring access and availability for infant and children testing and treatment for pregnant women and mothers.

Encouraging all stakeholders in maternal and child health to consider integrating hepatitis B interventions into antenatal care services together with the HIV, the Syphilis, and PMTCT programme, Dr Mulombo pledged WHO’s commitment to continuing partnership with Federal Ministry of Health, National AIDS/STI Control Program (NASCAP)and other departments as well as partners and stakeholders working on viral hepatitis through provision of technical support, and innovations towards the attainment of the set targets.
Dr Mulombo urged journalists to “champion this cause to rapidly improve access to services to prevent, diagnose and treat hepatitis in Nigeria.”

Hepatitis is preventable, treatable and curable. There are five different hepatitis viruses, referred to as types A, B, C, D and E. While they all cause liver disease, they have different modes of transmission, severity of the illness, geographical distribution and prevention methods.

Technical Contacts:
Dr Jean Baptiste Anne Eudes; Email: jeana@who.int; Tel: +234 813 173 6281
Dr Oluwafunke Ilesanmi; Email: ilesanmio@who.int; +234 903 722 8596

For Additional Information or to Request Interviews, Please contact:

Ms Charity Warigon

Tel: +234 810 221 0093
Email: warigonc@who.int